Oncologists' perspectives on omission of sentinel lymph node biopsy in women >70 years with early-stage hormone receptor-positive breast cancer

被引：1
|
作者：
Minami, Christina Ahn
Bryan, Ava F.
Revette, Anna C.
Freedman, Rachel A.
King, Tari A.
Mittendorf, Elizabeth A.
机构：
[1] Brigham & Womens Hosp, Dana Farber Brigham & Womens Canc Ctr, Breast Oncol Program, Div Breast Surg,Dept Surg, Boston, MA USA
[2] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA
[3] Dana Farber Canc Inst, Survey & Data Management Core, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5] Dana Farber Brigham & Womens Canc Ctr, Div Breast Surg, Dept Surg, Breast Oncol Program,BWH, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 28期
关键词：
D O I：
10.1200/JCO.2020.39.28_suppl.48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy
    Jennifer E. Tonneson
    Tanya L. Hoskin
    Diane M. Durgan
    Kimberly S. Corbin
    Matthew P. Goetz
    Judy C. Boughey
    [J]. Annals of Surgical Oncology, 2021, 28 : 8766 - 8774
  • [32] Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy
    Tonneson, Jennifer E.
    Hoskin, Tanya L.
    Durgan, Diane M.
    Corbin, Kimberly S.
    Goetz, Matthew P.
    Boughey, Judy C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) : 8766 - 8774
  • [33] Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer
    Sestak, Ivana
    Zhang, Yi
    Schroeder, Brock E.
    Schnabel, Catherine A.
    Dowsett, Mitch
    Cuzick, Jack
    Sgroi, Dennis
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (20) : 5043 - 5048
  • [34] Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
    Knape, Nicole
    Park, Ji-Hye
    Agala, Chris B.
    Spanheimer, Philip
    Morrow, Monica
    Downs-Canner, Stephanie
    Baldwin, Xavier L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 1042 - 1050
  • [35] Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?
    Nicole Knape
    Ji-Hye Park
    Chris B. Agala
    Philip Spanheimer
    Monica Morrow
    Stephanie Downs-Canner
    Xavier L. Baldwin
    [J]. Annals of Surgical Oncology, 2023, 30 : 1042 - 1050
  • [36] Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer
    Reeder-Hayes, Katherine E.
    Bainbridge, John
    Meyer, Anne Marie
    Amos, Keith D.
    Weiner, Bryan J.
    Godley, Paul A.
    Carpenter, William R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 863 - 871
  • [37] Rates of Compliance with De-Escalation Guidelines in Southern West Virginia for Women ≥ 70 Years with Early-Stage, Hormone Receptor-Positive Breast Cancer
    Gerwog, Madeline
    Ronaghan, Catherine A.
    Sheerer, Mary
    Puckett, Yana
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S93 - S93
  • [38] Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer
    Katherine E. Reeder-Hayes
    John Bainbridge
    Anne Marie Meyer
    Keith D. Amos
    Bryan J. Weiner
    Paul A. Godley
    William R. Carpenter
    [J]. Breast Cancer Research and Treatment, 2011, 128 : 863 - 871
  • [39] Incident comorbidities in a diverse cohort of women treated for early-stage, hormone receptor-positive breast cancer
    Gupta, Tanya
    Purington, Natasha
    Liu, Mina
    Han, Summer
    Sledge, George
    Schapira, Lidia
    Kurian, Allison
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [40] Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes
    Kantor, Olga
    Weiss, Anna
    Burstein, Harold J.
    Mittendorf, Elizabeth A.
    King, Tari A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (12) : 7674 - 7682
12345